Innoviva vet Ronsheim joins Xenon

Neurology company Xenon Pharmaceuticals Inc. (NASDAQ:XENE) expanded its team, hiring Matthew Ronsheim as COO to lead CMC, program management and quality assurance, as the company prepares to launch azetukalner. Ronsheim was CTO and subsequently president of Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc. (NASDAQ:INVA).

Law firm Manatt, Phelps & Phillips named healthcare attorneys Pat Cerundolo, Erin Estey Hertzog and Ross Margulies partners.  All three join Manatt from Foley Hoag...